Single User License
INR 96375
Site License
INR 192750
Corporate User License
INR 289125

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Celltrion, Inc.-Product Pipeline Review-2015

Celltrion, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07173CDB
  • |
  • Pages: 47
  • |
  • June 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Celltrion, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Celltrion, Inc.-Product Pipeline Review-2015', provides an overview of the Celltrion, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celltrion, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Celltrion, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Celltrion, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Celltrion, Inc.'s pipeline products

Reasons To Buy

Evaluate Celltrion, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Celltrion, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Celltrion, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Celltrion, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celltrion, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Celltrion, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Celltrion, Inc. Snapshot 5

Celltrion, Inc. Overview 5

Key Information 5

Key Facts 5

Celltrion, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Celltrion, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Celltrion, Inc.-Pipeline Products Glance 13

Celltrion, Inc.-Late Stage Pipeline Products 13

Pre-Registration Products/Combination Treatment Modalities 13

Phase III Products/Combination Treatment Modalities 14

Celltrion, Inc.-Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

Celltrion, Inc.-Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Celltrion, Inc.-Drug Profiles 19

infliximab biosimilar 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

rituximab biosimilar 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

trastuzumab biosimilar 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

CTP-27 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

adalimumab biosimilar 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

bevacizumab biosimilar 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

cetuximab biosimilar 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

CTP-19 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

CTP-26 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

etanercept biosimilar 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

palivizumab biosimilar 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

CTP-24 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

CTP-25 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Celltrion, Inc.-Pipeline Analysis 35

Celltrion, Inc.-Pipeline Products by Target 35

Celltrion, Inc.-Pipeline Products by Route of Administration 36

Celltrion, Inc.-Pipeline Products by Molecule Type 37

Celltrion, Inc.-Pipeline Products by Mechanism of Action 38

Celltrion, Inc.-Recent Pipeline Updates 39

Celltrion, Inc.-Dormant Projects 43

Celltrion, Inc.-Dormant Projects 43

Celltrion, Inc.-Company Statement 44

Celltrion, Inc.-Locations And Subsidiaries 45

Head Office 45

Appendix 46

Methodology 46

Coverage 46

Secondary Research 46

Primary Research 46

Expert Panel Validation 46

Contact Us 46

Disclaimer 47

List of Tables

Celltrion, Inc., Key Information 5

Celltrion, Inc., Key Facts 5

Celltrion, Inc.-Pipeline by Indication, 2015 7

Celltrion, Inc.-Pipeline by Stage of Development, 2015 9

Celltrion, Inc.-Monotherapy Products in Pipeline, 2015 10

Celltrion, Inc.-Partnered Products in Pipeline, 2015 11

Celltrion, Inc.-Partnered Products/ Combination Treatment Modalities, 2015 12

Celltrion, Inc.-Pre-Registration, 2015 13

Celltrion, Inc.-Phase III, 2015 14

Celltrion, Inc.-Phase II, 2015 15

Celltrion, Inc.-Phase I, 2015 16

Celltrion, Inc.-Preclinical, 2015 17

Celltrion, Inc.-Discovery, 2015 18

Celltrion, Inc.-Pipeline by Target, 2015 35

Celltrion, Inc.-Pipeline by Route of Administration, 2015 36

Celltrion, Inc.-Pipeline by Molecule Type, 2015 37

Celltrion, Inc.-Pipeline Products by Mechanism of Action, 2015 38

Celltrion, Inc.-Recent Pipeline Updates, 2015 39

Celltrion, Inc.-Dormant Developmental Projects,2015 43

List of Figures

Celltrion, Inc.-Pipeline by Top 10 Indication, 2015 7

Celltrion, Inc.-Pipeline by Stage of Development, 2015 9

Celltrion, Inc.-Monotherapy Products in Pipeline, 2015 10

Celltrion, Inc.-Partnered Products in Pipeline, 2015 11

Celltrion, Inc.-Pipeline by Top 10 Target, 2015 35

Celltrion, Inc.-Pipeline by Top 10 Route of Administration, 2015 36

Celltrion, Inc.-Pipeline by Top 10 Molecule Type, 2015 37

Celltrion, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Celltrion, Inc.; Celltrion, Inc. - Key Therapeutics; Celltrion, Inc. - Pipeline Overview and Promising Molecules; Celltrion, Inc. - News; Celltrion, Inc. - Latest Updates; Celltrion, Inc. - Pipeline; Celltrion, Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]